ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

Adamopoulos, Stamatis; Anker, Stefan D.; Falk, Volkmar; Køber, Lars; Maggioni, Aldo P.; Parkhomenko, Alexander; Pieske, Burkert; Popescu, Bogdan A; Rutten, Frans H.; Schwitter, Juerg; Trindade, Pedro T.; Voors, Adriaan A.; Zeiher, Andreas M.

doi:10.1093/eurheartj/ehs104

Cited by 5,339 publications

(3,139 citation statements)

References 259 publications

Supporting

Mentioning

2,841

Contrasting

Unclassified

231

Order By: Relevance

“…The accurate and timely diagnosis of HF is critical for guiding appropriate treatment,3, 4 yet diagnostic tests are underutilized by many clinicians, as evidenced in the Study on Heart failure Awareness and Perception Europe and EuroHeart Failure Survey 5, 6. In primary care, reluctance to use certain tests, including echocardiography, may be due to lack of knowledge about how to interpret results 18…”

Section: Discussionmentioning

confidence: 99%

“…Others reported that HF patient education was not part of their role as a member of the HF care team. However, the ESC guidelines emphasize the critical role of patient education is supporting optimal patient outcomes 3. To enhance confidence around patient education, PCPs, primary care nurses, and cardiac nurses would benefit from a checklist of key patient education topics, as well as practical tools for improving patient/HCP communication.…”

Section: Discussionmentioning

confidence: 99%

“…The survey was designed to assess key areas of HF knowledge and clinical practice based on the 2012 European Society of Cardiology (ESC) guidelines 3. Survey questions were developed from a literature review, preliminary needs assessment, and expert opinion and then reviewed and approved by the international and multidisciplinary CORE Steering Committee members (Appendix 1).…”

Section: Methodsmentioning

confidence: 99%

“…Moreover, given the ageing population and prolonged survival of patients with cardiovascular disease, the prevalence and public health burden of HF are expected to grow 2. Therefore, the effective diagnosis and treatment of patients with HF are essential 3, 4. However, many patients with HF are not receiving treatments and/or appropriate doses that demonstrate benefit in clinical trials and are not receiving care within a multidisciplinary framework that emphasizes effective long‐term management 5, 6, 7…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey

et al. 2017

View full text Add to dashboard Cite

AimsCORE is a continuing medical education initiative designed to support the evidence‐based management of heart failure (HF) in the primary and secondary care settings. The goal of the CORE Needs Assessment Survey is to describe current clinical practice patterns and attitudes among global stakeholders in HF care.Methods and resultsThe CORE Steering Committee guided the development of survey questions to assess clinical practice, confidence, and attitudes/perceptions among cardiologists, primary care physicians, and nurses involved in HF management. In total, 346 healthcare professionals from Australia (n = 59), Austria (n = 59), Canada (n = 60), Spain (n = 58), Sweden (n = 52), and the UK (n = 58) contributed survey data. Results revealed multiple gaps over the spectrum of HF care, including diagnosis (low recognition of the signs and symptoms of HF and limited use of diagnostic tests), treatment planning (underuse of recommended agents and subtherapeutic dosing), treatment monitoring and adjustment (lack of adherence to recommendations), and long‐term management (low confidence in providing patient education). Although primary care and specialist physicians and nurses shared common unmet needs, healthcare professional‐specific clinical gaps were also identified.ConclusionsThe CORE Needs Assessment Survey provides timely data describing current clinical practices and attitudes among physicians and nurses regarding key aspects of HF care. These findings will be useful for guiding the development of interventions tailored to the specific educational needs of different provider types and designed to support the evidence‐based care of patients with HF.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Use of b‐type natriuretic peptide (BNP) and the physiologically inert cleaved fragment, N‐terminal‐pro‐b‐type natriuretic peptide (NT‐proBNP), are guideline recommended by for the evaluation of dyspnea 2, 3. BNP and/or NT‐proBNP levels correlate with HF diagnosis, severity, and mortality 4, 5.…”

Section: Introductionmentioning

confidence: 99%

Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)

Bhatt

Cooper

Ambrosy

et al. 2018

JAHA

View full text Add to dashboard Cite

BackgroundHigher body mass index (BMI) is associated with lower circulating levels of N‐terminal‐pro‐b‐type natriuretic peptide (NT‐proBNP). The Interaction between BMI and NT‐proBNP with respect to clinical outcomes is not well characterized in patients with acute heart failure.Methods and ResultsA total of 686 patients from the biomarker substudy of the ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated HF ) clinical trial with documented NT‐proBNP levels at baseline were included in the present analysis. Patients were classified by the World Health Organization obesity classification (nonobese: BMI <30 kg/m2, Class I obesity: BMI 30–34.9 kg/m2, Class II obesity BMI 35–39.9 kg/m2, and Class III obesity BMI ≥40 kg/m2). We assessed baseline characteristics and 30‐ and 180‐day outcomes by BMI class and explored the interaction between BMI and NT‐proBNP for these outcomes. Study participants had a median age of 67 years (55, 78) and 71% were female. NT‐proBNP levels were inversely correlated with BMI (P<0.001). Higher NT‐proBNP levels were associated with higher 180‐day mortality (adjusted hazard ratio for each doubling of NT‐proBNP, 1.40; 95% confidence interval, 1.16, 1.71; P<0.001), but not 30‐day outcomes. The effect of NT‐proBNP on 180‐day death was not modified by BMI class (interaction P=0.24).ConclusionsThe prognostic value of NT‐proBNP was not modified by BMI in this acute heart failure population. NT‐proBNP remains a useful prognostic indicator of long‐term mortality in acute heart failure even in the obese patient.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00475852.

show abstract

Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

Lund¹,

Benson²,

Dahlström³

et al. 2012

JAMA

158

107

View full text Add to dashboard Cite

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

Cited by 5,339 publications

References 259 publications

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey

Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)

Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

Contact Info

Product

Resources

About